We are live on ! Find out more
CIA

Compass Ion Advisors Portfolio holdings

AUM $1.05B
1-Year Est. Return 16.28%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+16.28%
3 Year Est. Return
+56.71%
5 Year Est. Return
+49.21%
10 Year Est. Return
AUM
$194M
AUM Growth
Cap. Flow
+$189M
Cap. Flow %
97.59%
Top 10 Hldgs %
85.58%
Holding
54
New
54
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 1.75%
2 Healthcare 1.08%
3 Industrials 0.85%
4 Consumer Discretionary 0.74%
5 Technology 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRST
51
Trustco Bank Corp NY
TRST
$972M
$173K 0.09%
+4,000
New +$171K
ACB
52
Aurora Cannabis
ACB
$173M
$75K 0.04%
+291
New +$108K
HEXO
53
DELISTED
HEXO Corp. Common Shares
HEXO
$22K 0.01%
+248
New +$32.7K
OTLKW
54
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$2K ﹤0.01%
+20,000
New +$2.07K

Similar funds

Compass Ion Advisors's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Compass Ion Advisors, which disclosed 54 positions worth $194M. Its ten largest holdings account for 86% of the portfolio.

Its largest position is iShares Core Moderate Allocation ETF: 1,271,336 shares worth $51M.

By sector, the portfolio is most concentrated in Financials at 1.8% of assets, followed by Healthcare and Industrials.

  • Compass Ion Advisors's largest Q4 2019 buy was iShares Core Moderate Allocation ETF: 1,271,336 shares worth $51M.
  • Compass Ion Advisors's ten largest holdings make up 86% of its $194M portfolio in Q4 2019.
  • Compass Ion Advisors disclosed 54 positions in Q4 2019, its first 13F filing on record.

Based on Compass Ion Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.